FMC FMC CORP
Chemicals & Allied Products · NYSE · SEC CIK 37785 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-22.0%
TTM net income YoY-696.3%
TTM EPS YoY-678.8%
Revenue 3-yr CAGR-17.2%
Net income 3-yr CAGR—
Margins
Gross margin22.0%
Operating margin-97.0%
Net margin-151.2%
FCF margin13.1%
EBITDA margin-91.0%
Returns
ROE-226.7%
ROA-42.6%
ROIC (approx.)-38.4%
Asset turnover0.28x
Leverage & solvency
Liabilities / assets99.9%
Debt / equity—
Current ratio1.66x
Interest coverage-9.96x
Cash quality & payout
Operating cash flow / net income-0.10x
Accruals ratio-46.8%
Payout ratio—
Capex / revenue2.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q42025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q42024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $105.90M | $867.10M | $758.60M | $1.08B | $542.20M | $1.05B | $791.40M | $1.22B |
| Cost of revenue | $507.50M | $525.00M | $512.00M | $652.20M | $413.30M | $644.20M | $474.70M | $699.60M |
| Gross profit | -$401.60M | $342.10M | $246.60M | $431.10M | $128.90M | $406.30M | $316.70M | $524.70M |
| R&D expense | $57.70M | $60.40M | $65.50M | $67.70M | $63.30M | $66.40M | $68.70M | $72.20M |
| SG&A expense | $172.30M | $179.10M | $185.10M | $168.70M | $167.40M | $176.80M | $172.00M | $156.70M |
| Operating income | -$1.11B | -$119.70M | -$81.00M | -$1.42B | -$396.30M | $126.40M | $58.20M | $234.60M |
| Interest expense | $73.60M | $71.30M | $64.80M | $64.40M | $64.10M | $61.00M | $50.10M | $51.80M |
| Pretax income | -$1.19B | -$194.30M | -$149.20M | -$1.48B | -$466.00M | $58.80M | $4.90M | $177.50M |
| Income tax | $840.60M | -$1.50M | $112.10M | $204.10M | $82.20M | $14.40M | $13.50M | $148.00M |
| Net income | -$2.07B | -$186.60M | -$281.30M | -$1.72B | -$569.30M | $66.70M | -$15.50M | -$16.30M |
| EBITDA | -$1.07B | -$78.60M | -$39.00M | -$1.37B | -$352.90M | $169.80M | $101.90M | $277.70M |
| EPS (basic) | -15.54 | -1.49 | -2.25 | -13.74 | -4.52 | 0.53 | -0.12 | -0.13 |
| EPS (diluted) | -15.54 | -1.49 | -2.25 | -13.74 | -4.52 | 0.53 | -0.12 | -0.13 |
| Dividends declared per share | 0.08 | 0.08 | 0.08 | 1.74 | 0.58 | 0.58 | 0.58 | 0.58 |
| Weighted avg. shares (diluted) | 133.05M | 125.40M | 125.28M | — | 125.20M | 125.57M | 125.08M | 125.50M |
| Balance sheet | ||||||||
| Cash & equivalents | $735.80M | $476.60M | $390.90M | $584.50M | $497.70M | $438.20M | $315.30M | $357.30M |
| Receivables | $1.72B | $2.07B | $2.24B | $2.06B | $2.33B | $3.08B | $2.90B | $2.90B |
| Inventory | $1.33B | $1.21B | $1.24B | $1.22B | $1.38B | $1.40B | $1.37B | $1.20B |
| Current assets | $4.58B | $4.73B | $4.90B | $4.96B | $5.57B | $5.47B | $5.08B | $4.96B |
| PP&E, net | $491.90M | $554.70M | $627.50M | $707.40M | $855.40M | $890.70M | $858.70M | $849.70M |
| Goodwill | — | — | — | $0 | $1.36B | $1.53B | $1.52B | $1.51B |
| Intangibles | $2.00B | $2.31B | $2.33B | $2.36B | $2.38B | $2.40B | $2.37B | $2.36B |
| Total assets | $7.91B | $9.14B | $9.42B | $9.69B | $12.08B | $12.30B | $11.80B | $11.65B |
| Current liabilities | $2.76B | $2.38B | $3.81B | $3.76B | $3.99B | $3.57B | $3.31B | $3.02B |
| Short-term debt | $222.80M | $326.30M | $1.76B | $1.31B | $1.27B | $893.30M | $975.80M | $337.40M |
| Long-term debt | $3.95B | $3.95B | $2.77B | $2.77B | $3.27B | $3.27B | $3.03B | $3.03B |
| Total debt | $4.18B | $4.28B | $4.53B | $4.07B | $4.54B | $4.16B | $4.00B | $3.37B |
| Total liabilities | $7.90B | $7.48B | $7.57B | $7.59B | $8.28B | $7.87B | $7.39B | $7.14B |
| Shareholders' equity | -$19.40M | $1.64B | $1.82B | $2.07B | $3.77B | $4.40B | $4.38B | $4.49B |
| Net debt | $3.44B | $3.80B | $4.14B | $3.49B | $4.04B | $3.73B | $3.69B | $3.01B |
| Cash flow statement | ||||||||
| Operating cash flow | $6.60M | $363.00M | -$600.90M | $657.10M | -$184.20M | $65.90M | -$545.00M | $427.90M |
| Capital expenditure | $7.80M | $5.30M | $16.60M | $26.00M | $23.70M | $15.00M | $31.60M | $21.60M |
| Free cash flow | -$1.20M | $357.70M | -$617.50M | $631.10M | -$207.90M | $50.90M | -$576.60M | $406.30M |
| Investing cash flow | -$8.20M | $6.20M | -$16.20M | -$15.30M | -$33.00M | -$13.40M | -$38.00M | $319.50M |
| Financing cash flow | $278.90M | -$263.40M | $442.30M | -$546.10M | $303.40M | $76.60M | $552.10M | -$768.60M |
| Depreciation & amortization | $40.90M | $41.10M | $42.00M | $43.10M | $43.40M | $43.40M | $43.70M | $43.10M |
| Stock-based compensation | $7.30M | $7.70M | $3.00M | $6.10M | $6.80M | $6.90M | $4.20M | $5.70M |
| Dividends paid | $10.20M | $10.20M | $10.00M | $72.90M | $72.90M | $72.80M | $72.70M | $72.70M |
| Share buybacks | — | — | — | — | — | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.